Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PY3L
|
|||
| Former ID |
DNCL002165
|
|||
| Drug Name |
MEDI-565
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Gastrointestinal cancer [ICD-11: 2C11] | Phase 1 | [1] | |
| Company |
MedImmune
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01284231) A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas. U.S. National Institutes of Health. | |||
| REF 2 | Bispecific antibodies rise again. Nat Rev Drug Discov. 2014 Nov;13(11):799-801. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.